Dr. Christie Ballantyne, professor of medicine and section chief of cardiology and cardiovascular research in the department of medicine at Baylor College of Medicine, was awarded the Louis M. Sherwood Award at the Association of Clinical Research Professionals 2012 Global Conference & Exhibition.
Ballantyne, who is also the director of the Center for Cardiovascular Disease Prevention at the Methodist DeBakey Heart Center and co-director of the Lipid Metabolism and Atherosclerosis Clinic at The Methodist Hospital, was recognized for his commitment to clinical research on the prevention and treatment of atherosclerotic vascular disease, including lipid-lowering drug therapy and identifying novel biomarkers to help those at high risk for cardiovascular disease.
"This award means a lot to me as I knew Lou Sherwood. I have been fortunate to have had a career in which I have been involved in basic, translational and clinical research and to have participated in trials testing therapies that have completely changed the field of preventive cardiology," Ballantyne said.
In addition to his research and patient care, Ballantyne is also director of the Maria and Alando J. Ballantyne Atherosclerosis Clinical Research Laboratory, a fellow of the American Association for the Advancement of Science, the American College of Cardiology, and the American College of Physicians, a member of the American Society for Clinical Investigation and editorial director for Lipids Online.
The ACRP 2012 Global Conference & Exhibition, which took place in Houston April 14-17, is the largest annual professional development and networking event for clinical research professionals focused on clinical trials, including discussions on regulatory changes and tools to improve efficiency and performance.
The Louis M. Sherwood Award is named in honor of a past president of the Academy of Pharmaceutical Physicians and Investigators, which was recently renamed the Academy of Physicians in Clinical Research.